Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Interventional cardiologists implant new-look heart device for first time in US
The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.
IVL may be safer than atherectomy in patients with severely calcified lesions
Researchers explored data from more than 1,000 patients with calcified coronary artery disease who required plaque modification. IVL and atherectomy were linked to comparable success rates, but adverse events were less likely with IVL.
Cardiologists should always be involved when heart issues arise after surgery
Cardiac complications after noncardiac surgeries are a significant concern, especially as patients keep living longer and surgical volumes continue to rise.
Russia rolls out MosMed.AI to standardize healthcare AI nationwide
Initiatives include radiology image reading, data analytics, remote patient monitoring, speech recognition and more. Most of the federation has adopted the standards of the artificial intelligence platform.
New injectable therapy could help limit brain damage in stroke patients
Early research suggests a single injection could reduce both brain damage and inflammation if delivered after a patient experiences a stroke. Much more research is still needed, but the new therapy showed significant potential.

The Sapien 3 prosthesis continues to impress, though researchers must continue to monitor its performance as time goes on.

This is the third such renewal and will prolong the PHE into January, Secretary Alex Azar said.

More research on long-term outcomes is still needed before TAVR can be recommended for such patients across the board.

More lots of extended-release metformin have been recalled due to high levels of NDMA, a contaminant associated with cancer.

The study's authors explored data from more than 1,500 patients treated with hydroxychloroquine and more than 3,000 who received usual care.

While metoprolol was linked with limiting infarct size, two other beta-blockers—atenolol and propranolol—were not associated with such improvements.

A Miami cardiologist is speaking out about the “irresponsible” way President Donald Trump has acted following his COVID-19 diagnosis.

A “similar, but weaker" association was observed for angiotensinogen II receptor blockers.